SCA
AGN

SAC Capital Advisors’s Allergan Inc AGN Stock Holding History

SAC Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-20,480
Closed -$2.54M – 1710
2014
Q1 		$2.54M Sell
20,480
-118,639
-85% -$14.4M 0.01% 712
2013
Q4 		$15.5M Sell
139,119
-476,480
-77% -$45.5M 0.09% 273
2013
Q3 		$55.7M Buy
615,599
+549,467
+831% +$49.3M 0.3% 90
2013
Q2 		$5.57M Buy
+66,132
New +$6.86M 0.03% 507

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SAC Capital Advisors's AGN Position: Q2 2014 in Review

SAC Capital Advisors sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 20,480 shares — an estimated $2.54M sold.

SAC Capital Advisors first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $55.7M in Q3 2013. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • SAC Capital Advisors reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 20,480 Allergan Inc shares in Q2 2014, an estimated $2.54M.
  • SAC Capital Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Allergan Inc position peaked at $55.7M in Q3 2013.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.